The plant investigation is in process.
A supplemental mdr will be submitted upon completion of this activity.
clinical investigation: based on the available information, there is a likely causal relationship between the fresenius optiflux 180nr dialyzer and the patient¿s reaction (characterized by lip swelling and itching during the hd treatment).
Although rare, hypersensitivity or anaphylactoid reactions to optiflux dialyzers are a known risk during hemodialysis.
There is no evidence of an optiflux 180nr dialyzer product deficiency or malfunction.
Additionally, although the patient experienced an adverse reaction during treatment, there is no allegation of a product malfunction or deficiency related to this event.
|
It was reported during follow up to (b)(6) that the patient was utilizing the optiflux 180nr dialyzer and then experienced lip swelling and itching.
The hemodialysis (hd) treatment was stopped, and the patient was administered benadryl (route and dose unknown).
The patient did not require any additional intervention.
The patient went on to try dialyzers from different manufacturers; however, continues to experience minor reactions.
The patient is now being administered benadryl prior to treatment.
It was not confirmed which dialyzer the patient is currently utilizing for treatments.
|